Laurus Labs Ltd IPO Message Board (Page 59)

Apply guys, very good company for short term and long-term as well.

LAURUS LABS WILL PROVE TO BE A GOOD ISSUE AFTER A LONG TIME.

15-20% listing gain expected this ipo..
Apply..

As we know that, there is no doubt that he fundamentals of this company are very strong. This is going to give a good return....but not able to understand why there is a moderate response from Retail investors on the very first day...

It usually picks up on the very last day. Few analysts have stated that the asking price is on the higher side. But given the growth of the company within a short span of time, EBITDA would be a better metric to assess the tremendous growth trajectory of Lauras.
The GMP is currently looking good, I think this stock would appreciate in value very quickly.

Yes. I agree. But, as we have seen that Sheela could not attract retail investors...the same way what happens if Lauras walks on the same path...Laurus should have been oversubscribed on the very first day...that is what I was expecting....anyway...two days are in hands...may get subscribed three time (Retail quota)

Septa ji & Eagleye please reply do we need to Apply for this IPO?

How will it be in long run?

Is it a kind of Advanced Enzyme IPO?

Good response from both Q1B and NII on first day.
Don''t look at GMP, Just Apply blindly....AND HOPE FOR Allotment

donot forget that for this IPO, GMP is only indicative and not genuine GMP. more over when on last days, strong flow of applications come, GMP rises. and in this case also GMP will increase on last day.
So my opinion to start collecting on today''s gmp.

Is it true Lauras GMP is 30? Pl confirm.

Don''t go with gmp,just apply

Estimates posted previously on this chat were a lot higher.

It should be noted that on Monday Laurus Labs allotted 92.38 lakh shares at Rs 428 a share to 25 anchor investors raising about Rs 395.40 crore ahead of the public issue- Considering this, the overall picture is as follows;

Total Issue Size: 24,107,440
Total allotted to Anchors Pre IPO Day 0: 9,238,000
Total Bids on Day 1 of IPO: 5,207,755
Issue subscribed end of Day1: 0.59

Correction (based on NSE demand schedule summary)

otal Issue Size: 24,107,440
Total allotted to Anchors Pre IPO Day 0: 9,238,000
Total Bids on Day 1 of IPO: 6,209,420
Issue subscribed end of Day1: 0.64

Dear all experts

Anybody knows the difference between basic & diluted earning per share ( EPS ) ?

Thank you for sharing your knowledge

@share view! Don''t u know the simple thing? I think u r a novice. Learn atleast basic thing, before writing here.

@evergreen, don''t discourage any member, everybody are free to ask whatever confusions are there, for every positive approach, this forum should not be restricting in any manner.

I may be wrong.subscription details please.

Total Issue Size      2,19,11,308
Total Bids Received      62,09,420
Total Bids Received at Cut-off Price      8,57,290
No. of times issue is subscribed      0.28

I do not think below subscription details are correct. I can see in IPO central it is subscribed 5 times as of now.please check and confirm. Which is correct.

QIB--0.71
HNI--0.20
RETAIL-0.08
EMPLOYEE-0.03.. TILL 4.30

Cummulative Bid and Quantity for LAURUS LABS LIMITED
At BSE-NSE
Last updated on 
Tuesday, December 06 , 2016 4:00:00 PMPrice ()Quantity
426.00 58,33,800
427.00 58,29,705
428.00 58,28,865
Cut-off 7,08,610

@ ICAN

Got it

Thank you

http://www.bseindia.com/markets/publicIssues/DisplayIPO.aspx?id=1231&type=IPO&idtype=1&status=L&IPONo=2302&startdt=12%2f6%2f2016

for all exchanges.

On day one QIB have started subscribing to the IPO. They usually come on the last day.

QIB portion subscribed 70 % on day one.

This QIB portion is through Anchor Investor, who comes on First day.

Anchor investor amount is deducted from the QIB portion. This is the correct QIB subscription excluding anchors.

Subscription of Laurus Labs as on 5 December 2016 @ 4 Pm
First Day of Laurus Labs

FII :- 70 % Subscribed
NIIs:- 16 % Subscribed
RIIs :- 5% Subscribed
Overall :- 23 % Subscribed

Not at all Bad figures for first day :) FIIs are lapping this IPO. Laurus labs has caught fancy of FII''s

Lauras Labs Ltd
EPS 19
PE 22.5

Peer companies:
Aurobindo : 25 PE
Divis : 28 PE
so reasonably priced and enough room for rise on listing.

This IPO can have listing at rs. 480 to 500 and in couple of days will scale to Rs. 600 and then move towards Rs. 700 just like Alkem and other pharma scrips recently listed.

Regards
Anish

EPS is 12.5 and not 19

It wwill go 1000 by end of 2017

Eagleye Latest subscription of Lauras lab???

Just In

According to Daljeet singh Kohli of Indianivesh on CNBC Awaaz , Everything is good but price.Co. made mistake in pricing at 428.
Its aggressive pricing . He recommended to buy after listing at lower price for long term . He remains neutral on subscription
while most of of the brokerage houses are negative . it is confusing , better to wait & watch till last day 1 pm and wait for another good IPO.

@ share view! If u r confused, y the hell are you here? I think you are a shameless creep to show off everywhere.

High profit growth, good op. profit margin but low net profit margin due to FC and D&A,
In EV_to_EBITDA terms not too cheaper than Divis and Aurobindo but in PEG terms significantly cheaper than Divis.
NPM low due to high D&A and FC. OCF_to_Sales ratio is .12.
OCF_to_NP is 1.5 and 88 % of the OCF is reflecting in the NP.